Gilead Sciences Stock Beta

GILD Stock  USD 73.25  0.24  0.33%   
Gilead Sciences fundamentals help investors to digest information that contributes to Gilead Sciences' financial success or failures. It also enables traders to predict the movement of Gilead Stock. The fundamental analysis module provides a way to measure Gilead Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gilead Sciences stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Gilead Beta Analysis

Gilead Sciences' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
 2021 2022 2023 2024 (projected)
Total Revenue27.3B27.3B27.1B28.5B
Interest Expense1.0B935M944M534.5M

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Gilead Sciences Beta

    
  0.2  
Most of Gilead Sciences' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gilead Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Gilead Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Gilead Sciences is extremely important. It helps to project a fair market value of Gilead Stock properly, considering its historical fundamentals such as Beta. Since Gilead Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Gilead Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Gilead Sciences' interrelated accounts and indicators.
0.90.950.70.93-0.05-0.12-0.270.990.610.620.730.470.560.530.910.240.87-0.77-0.510.820.690.96-0.250.690.210.730.24-0.58-0.48-0.26
0.90.90.640.87-0.1-0.2-0.530.880.530.420.650.360.470.320.760.270.82-0.64-0.440.750.670.89-0.370.460.340.610.29-0.55-0.48-0.48
0.950.90.540.950.03-0.18-0.360.90.590.520.740.410.460.370.790.410.86-0.65-0.40.720.630.88-0.30.640.180.630.22-0.62-0.39-0.36
0.70.640.540.48-0.27-0.01-0.240.750.190.620.210.350.540.410.64-0.180.74-0.81-0.670.890.740.70.180.580.060.690.3-0.54-0.6-0.28
0.930.870.950.48-0.03-0.27-0.280.90.760.440.770.540.40.470.860.340.74-0.61-0.220.70.480.9-0.490.560.370.520.32-0.46-0.23-0.21
-0.05-0.10.03-0.27-0.030.210.47-0.090.23-0.310.27-0.11-0.260.060.040.44-0.30.40.27-0.46-0.450.02-0.21-0.360.28-0.130.210.430.270.36
-0.12-0.2-0.18-0.01-0.270.210.08-0.09-0.05-0.03-0.12-0.080.02-0.05-0.04-0.17-0.070.0-0.02-0.090.0-0.110.34-0.02-0.22-0.12-0.10.03-0.050.02
-0.27-0.53-0.36-0.24-0.280.470.08-0.230.05-0.11-0.040.08-0.030.35-0.050.04-0.530.20.24-0.44-0.53-0.210.05-0.20.0-0.1-0.070.550.320.9
0.990.880.90.750.9-0.09-0.09-0.230.60.640.710.490.580.580.930.160.85-0.8-0.540.830.70.96-0.230.690.220.750.24-0.55-0.49-0.21
0.610.530.590.190.760.23-0.050.050.60.150.580.750.020.440.750.190.21-0.310.320.34-0.10.69-0.710.110.680.020.460.10.320.21
0.620.420.520.620.44-0.31-0.03-0.110.640.150.170.520.40.210.5-0.050.66-0.9-0.60.630.670.520.270.7-0.450.64-0.42-0.58-0.38-0.19
0.730.650.740.210.770.27-0.12-0.040.710.580.170.120.330.470.790.520.52-0.28-0.280.320.320.76-0.330.330.350.580.22-0.11-0.380.09
0.470.360.410.350.54-0.11-0.080.080.490.750.520.120.060.320.55-0.020.18-0.610.230.440.00.51-0.420.210.280.010.09-0.030.370.17
0.560.470.460.540.4-0.260.02-0.030.580.020.40.330.060.650.470.010.58-0.57-0.670.540.640.490.220.64-0.170.73-0.08-0.46-0.63-0.1
0.530.320.370.410.470.06-0.050.350.580.440.210.470.320.650.650.110.25-0.36-0.250.370.160.58-0.250.460.250.470.290.0-0.180.36
0.910.760.790.640.860.04-0.04-0.050.930.750.50.790.550.470.650.170.65-0.68-0.350.70.470.96-0.290.530.390.640.35-0.24-0.340.08
0.240.270.41-0.180.340.44-0.170.040.160.19-0.050.52-0.020.010.110.170.120.030.0-0.13-0.020.24-0.31-0.02-0.010.21-0.020.05-0.010.03
0.870.820.860.740.74-0.3-0.07-0.530.850.210.660.520.180.580.250.650.12-0.77-0.730.870.930.760.10.81-0.130.790.07-0.86-0.72-0.57
-0.77-0.64-0.65-0.81-0.610.40.00.2-0.8-0.31-0.9-0.28-0.61-0.57-0.36-0.680.03-0.770.6-0.84-0.76-0.72-0.13-0.70.19-0.70.150.60.470.23
-0.51-0.44-0.4-0.67-0.220.27-0.020.24-0.540.32-0.6-0.280.23-0.67-0.25-0.350.0-0.730.6-0.56-0.89-0.42-0.54-0.640.45-0.90.230.620.930.36
0.820.750.720.890.7-0.46-0.09-0.440.830.340.630.320.440.540.370.7-0.130.87-0.84-0.560.80.770.010.750.070.640.31-0.71-0.53-0.41
0.690.670.630.740.48-0.450.0-0.530.7-0.10.670.320.00.640.160.47-0.020.93-0.76-0.890.80.580.350.76-0.340.83-0.13-0.85-0.86-0.6
0.960.890.880.70.90.02-0.11-0.210.960.690.520.760.510.490.580.960.240.76-0.72-0.420.770.58-0.340.570.360.690.34-0.37-0.41-0.12
-0.25-0.37-0.30.18-0.49-0.210.340.05-0.23-0.710.27-0.33-0.420.22-0.25-0.29-0.310.1-0.13-0.540.010.35-0.340.23-0.740.3-0.47-0.22-0.5-0.04
0.690.460.640.580.56-0.36-0.02-0.20.690.110.70.330.210.640.460.53-0.020.81-0.7-0.640.750.760.570.23-0.380.71-0.08-0.76-0.55-0.26
0.210.340.180.060.370.28-0.220.00.220.68-0.450.350.28-0.170.250.39-0.01-0.130.190.450.07-0.340.36-0.74-0.38-0.250.780.380.310.18
0.730.610.630.690.52-0.13-0.12-0.10.750.020.640.580.010.730.470.640.210.79-0.7-0.90.640.830.690.30.71-0.25-0.11-0.53-0.84-0.14
0.240.290.220.30.320.21-0.1-0.070.240.46-0.420.220.09-0.080.290.35-0.020.070.150.230.31-0.130.34-0.47-0.080.78-0.110.090.10.02
-0.58-0.55-0.62-0.54-0.460.430.030.55-0.550.1-0.58-0.11-0.03-0.460.0-0.240.05-0.860.60.62-0.71-0.85-0.37-0.22-0.760.38-0.530.090.590.74
-0.48-0.48-0.39-0.6-0.230.27-0.050.32-0.490.32-0.38-0.380.37-0.63-0.18-0.34-0.01-0.720.470.93-0.53-0.86-0.41-0.5-0.550.31-0.840.10.590.38
-0.26-0.48-0.36-0.28-0.210.360.020.9-0.210.21-0.190.090.17-0.10.360.080.03-0.570.230.36-0.41-0.6-0.12-0.04-0.260.18-0.140.020.740.38
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Gilead Sciences has a Beta of 0.2. This is 76.74% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

Gilead Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gilead Sciences' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gilead Sciences could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics of similar companies.
Gilead Sciences is currently under evaluation in beta category among related companies.

Gilead Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Gilead Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Gilead Sciences' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Gilead Sciences Institutional Holders

Institutional Holdings refers to the ownership stake in Gilead Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Gilead Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Gilead Sciences' value.
Shares
Norges Bank2023-12-31
16.1 M
Bank Of New York Mellon Corp2023-12-31
15.5 M
Northern Trust Corp2023-12-31
14 M
Legal & General Group Plc2023-12-31
12.5 M
Parnassus Investments, Llc2023-12-31
12 M
Amvescap Plc.2023-12-31
11.6 M
Nuveen Asset Management, Llc2023-12-31
11.5 M
Royal Bank Of Canada2023-12-31
10.6 M
Amundi2023-12-31
10.5 M
Blackrock Inc2023-12-31
122.8 M
Vanguard Group Inc2023-12-31
111.8 M
As returns on the market increase, Gilead Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Gilead Sciences is expected to be smaller as well.

Gilead Fundamentals

About Gilead Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Gilead Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gilead Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gilead Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company was incorporated in 1987 and is headquartered in Foster City, California. Gilead Sciences operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 14400 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Gilead Sciences Piotroski F Score and Gilead Sciences Altman Z Score analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.